glp 1 crohn's disease Ever wondered how obesity, IBD, and GLP‑1 medication all fit together? If so, come along to this month's IBD patient meeting, where the group will be joined by Dr Chris Roberts for GI and Hepatology News -

Proper evaluation of obesity-related complications, contraindications, diabetes status, thyroid and pancreatic history, kidney and liver function, nutritional status, and concurrent medications is essential before initiating treatment. He argued that obesity is a complex, chronic disease, not a cosmetic problem, and that only doctors trained in hormones and metabolism carry the knowledge to prescribe these drugs safely

If your next scheduled dose is more than four days (96 hours) away, take the missed dose as soon as possible

What is the recommended BPC-157 dose for someone with hepatic impairment

The COA is just the start